Cerebral Near-infrared Spectroscopy in Patients Undergoing Open Cardiovascular Surgery Using Artificial Intelligence Programs: A Methodological Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorAntalya Health Sciences University

About this trial

The aim of the present study is to test the accuracy and reliability of AI tools in this regard by interpreting NIRS, which we routinely use for monitoring cerebral perfusion in cardiovascular surgery, with AI tools and comparing this interpretation with the interpretations of two clinicians.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

open cardiac surgery

elective open heart surgery

aged 18-65

ASA score I-III

Disqualifiers

past ischemic event

carotid arter stenosis

BMI >30 kg/m2

serious liver or kidney disease

Trial population

Patients aged 18-65 years with ASA scores I-III and BMI \<30 kg/m2 who are scheduled for elective open heart surgery will be included.

Trial design

Design model

Other

Time perspective

Prospective

Treatments tested in this trial

  • CHATGPT GROUP

    Other intervention

    CHATGPT responses

  • GEMINI GROUP

    Other intervention

    GEMINI responses

  • COPILOT GROUP

    Other intervention

    COPILOT responses

  • CLINICIAN GROUP

    Other intervention

    CLINICIAN responses

Treatment groups

63 Participants
are divided into 4 treatment groups
Group A: CHATGPT GROUP1 intervention
Group B: GEMINI GROUP1 intervention
Group C: COPILOT GROUP1 intervention
Group D: CLINICIAN GROUP1 intervention

Trial outcomes

Primary outcomes

1

Clinical Experience

The proximity of AI programs to the clinical experience

Time frame
12 hour

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: